Literature DB >> 30523602

MiR-374a Activates Wnt/β-Catenin Signaling to Promote Osteosarcoma Cell Migration by Targeting WIF-1.

Weichao Li1,2, Zengdong Meng2, Tiannan Zou2, Gang Wang2, Yijing Su2, Shaoping Yao3, Xianrun Sun4.   

Abstract

MiR-374a was proved to take part in the initiation and development of several cancers. However, the molecular mechanism of miR-374a in osteosarcoma (OS) cells remains unclear. The aim of our research was to investigate the role of miR-374a in OS cells migration and clarify the potential mechanisms. Quantitative real-time PCR (qRT-PCR) and western blot analysis were applied to evaluate the expression of miR-374a and Wnt inhibitory factor-1 (WIF-1). Bioinformatical methods and luciferase reporter assay were carried out to predict and confirm the combination of miR-374a and WIF-1. Transwell and wound healing assays were performed to detect the migration capacity of OS cells. Lithium chloride (LiCl) was used to investigate the role of LiCl-activated Wnt/β-catenin signaling pathway in regulating cell migration. Our studies revealed that miR-374a was up-regulated whereas WIF-1 was down-regulated in OS cells. Besides, WIF-1 was the target of miR-374a by performing luciferase reporter assay. By transfection of miR-374a inhibitor and/or WIF-1 siRNA to OS cells, we found that miR-374a promoted the migration of OS cells. In addition, the inhibition of WIF-1 abolished the miR-374a inhibitor-induced migration suppression of OS cells. LiCl experiment revealed that miR-374a promoted OS cells migration by regulating Wnt/β-catenin signaling. In conclusion, miR-374a promotes OS cells migration by activating Wnt/β-catenin signaling pathway via targeting WIF-1.

Entities:  

Keywords:  Migration; Osteosarcoma (OS); Signaling pathway; Wnt inhibitory factor-1 (WIF-1); Wnt/β-catenin; miR-374a

Year:  2018        PMID: 30523602     DOI: 10.1007/s12253-018-0556-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  26 in total

1.  Wnt/beta-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC.

Authors:  Fan Yang; Qinghua Zeng; Guangyan Yu; Shenglin Li; Cun-Yu Wang
Journal:  Cell Signal       Date:  2005-08-09       Impact factor: 4.315

2.  Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.

Authors:  Urmo Võsa; Tõnu Vooder; Raivo Kolde; Krista Fischer; Kristjan Välk; Neeme Tõnisson; Retlav Roosipuu; Jaak Vilo; Andres Metspalu; Tarmo Annilo
Journal:  Genes Chromosomes Cancer       Date:  2011-07-11       Impact factor: 5.006

3.  MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis.

Authors:  Junchao Cai; Hongyu Guan; Lishan Fang; Yi Yang; Xun Zhu; Jie Yuan; Jueheng Wu; Mengfeng Li
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

4.  WNT inhibitory factor 1 promoter hypermethylation is an early event during gallbladder cancer tumorigenesis that predicts poor survival.

Authors:  Bin Lin; HaiJie Hong; XiaoJie Jiang; ChengZong Li; SiYuan Zhu; NanHong Tang; XiaoQian Wang; FeiFei She; YanLing Chen
Journal:  Gene       Date:  2017-04-22       Impact factor: 3.688

5.  Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.

Authors:  Sang Hyuk Lee; Bon Seok Koo; Jin Man Kim; Songmei Huang; Young Soo Rho; Woo Jin Bae; Hyun Jung Kang; Young Sook Kim; Jung Hwa Moon; Young Chang Lim
Journal:  J Pathol       Date:  2014-07-23       Impact factor: 7.996

6.  Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/β-Catenin signaling.

Authors:  Xugui Li; Qilin Lu; Wei Xie; Yang Wang; Guanqing Wang
Journal:  Biochem Biophys Res Commun       Date:  2018-01-09       Impact factor: 3.575

7.  Modular mechanism of Wnt signaling inhibition by Wnt inhibitory factor 1.

Authors:  Tomas Malinauskas; A Radu Aricescu; Weixian Lu; Christian Siebold; E Yvonne Jones
Journal:  Nat Struct Mol Biol       Date:  2011-07-10       Impact factor: 15.369

8.  Modulation of the osteosarcoma expression phenotype by microRNAs.

Authors:  Heidi M Namløs; Leonardo A Meza-Zepeda; Tale Barøy; Ingrid H G Østensen; Stine H Kresse; Marieke L Kuijjer; Massimo Serra; Horst Bürger; Anne-Marie Cleton-Jansen; Ola Myklebost
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240

Review 9.  Long noncoding RNAs in the progression, metastasis, and prognosis of osteosarcoma.

Authors:  Zuozhang Yang; Xiaojuan Li; Yihao Yang; Zewei He; Xin Qu; Ya Zhang
Journal:  Cell Death Dis       Date:  2016-09-29       Impact factor: 8.469

10.  microRNA-374a suppresses colon cancer progression by directly reducing CCND1 to inactivate the PI3K/AKT pathway.

Authors:  Yiyu Chen; Jingwen Jiang; Mengyang Zhao; Xiaojun Luo; Zixi Liang; Yan Zhen; Qiaofen Fu; Xiaojie Deng; Xian Lin; Libo Li; Rongcheng Luo; Zhen Liu; Weiyi Fang
Journal:  Oncotarget       Date:  2016-07-05
View more
  3 in total

1.  MicroRNA-202 inhibits cell migration and invasion through targeting FGF2 and inactivating Wnt/β-catenin signaling in endometrial carcinoma.

Authors:  Ping Chen; Tianrong Xing; Qingdong Wang; Ai Liu; Haiping Liu; Yuhong Hu; Yanjia Ji; Ying Song; Dongwei Wang
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

2.  miR-29a-3p inhibits the malignant characteristics of non-small cell lung cancer cells by reducing the activity of the Wnt/β-catenin signaling pathway.

Authors:  Kang Zhang; Xiaoliang Han; Wenbin Hu; Chao Su; Binjun He
Journal:  Oncol Lett       Date:  2022-09-12       Impact factor: 3.111

3.  Identification of KIF4A as a pan-cancer diagnostic and prognostic biomarker via bioinformatics analysis and validation in osteosarcoma cell lines.

Authors:  Jiankang Pan; Xiaohua Lei; Xinzhan Mao
Journal:  PeerJ       Date:  2021-05-21       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.